Immunology Market: How the Business Will Grow in 2025? Prominent Players: AbbVie Inc., Janssen Global Services, LLC (Johnson & Johnson), F. Hoffmann-La Roche Ltd, Amgen Inc., Pfizer Inc, Novartis, Astellas, Bristol-Myers Squibb Company, UCB SA, ALLERGAN,

The Global Immunology Market is likely to expand in the coming years driven by the high prevalence of immunological disorders, resulting from environmental factors. According to a report published by Fortune Business Insights, titled "Immunology Market: Global Market Analysis, Insights and Forecast, 2019-2026," the market was valued at US$ 77,365.4 Mn in 2018. Fortune Business Insights has predicted that the market will reach US$ 143,833.2 Mn by 2026 and will exhibit a CAGR of 8.1%.
Leading Players operating in the Immunology Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

o AbbVie Inc.
o Janssen Global Services,
o LLC (Johnson & Johnson)
o F. Hoffmann-La Roche Ltd
o Amgen Inc.
o Pfizer Inc
o Novartis
o Astellas
o Bristol-Myers Squibb Company
o Merck Sharp & Dohme Corp.
o UCB SA
o ALLERGAN.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/immunology-market-100657

The report covers:

o Global Immunology Market trends, with detailed analysis on consumer trends & manufacturer trends.
o Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors.
o Key areas of investments identifying market opportunities and challenges in forecast timeframe.
o Competitive analysis of the industry players along with the overview on strategic management.
o Comprehensive company profiles of the major industry players.

Recent Product Approvals by Regulatory Agencies to Bode Well for the Overall Market
The spate of recent regulatory approvals for the immunology products is anticipated to contribute to the overall positive growth of the market. For instance, the recent regulatory approval and the subsequent launch of TREMFYA (Guselkumab) by Janssen Global Services, LLC (Johnson & Johnson), is expected to lead to better outcome for the patients. TREMFYA (Guselkumab) was launched for the treatment of moderate to severe plaque psoriasis, a seriously debilitating immunological disorder.

Global Immunology Market Segmentation
By Drug Class
o Monoclonal antibody (mAb)
o Fusion Proteins
o Immunosuppressants
o Polyclonal antibody (pAb)
o Others
By Disease Indication
o Rheumatoid Arthritis
o Psoriatic Arthritis
o Plaque Psoriasis
o Ankylosing Spondylitis
o Inflammatory Bowel Disease
o Prophylaxis of Organ Rejection
o Others
By Distribution Channel
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
o Others
By Geography
o North America (U.S., and Canada)
o Europe (Germany, U.K., France, Italy, Spain, Scandinavia, and Rest of Europe)
o Asia Pacific (China, India, Japan, Australia, South East Asia, and Rest of Asia Pacific)
o Latin America (Brazil, Mexico, and the Rest of Latin America)
o Middle East & Africa (GCC, South Africa, and Rest of Middle East & Africa)

AbbVie Gains FDA Approval of SKYRIZI; Product to Witness High Demand in No Time
The global immunology market has gained impetus from the availability of several regulatory approved drugs. The approval of new drugs and the trends of improvements in clinical efficiencies will bode well for the global immunology market. In 2019, AbbVie received approval from the Food and Drug Administration (FDA) for the usage of 'SKYRIZI'. The drug was aimed at the treatment of moderate to severe plaque psoriasis. This drug was inclined towards the treatment of adults diagnosed with psoriasis and have been recommended for or undergoing therapy. The drug is likely to gain huge popularity among healthcare professionals and its high clinical efficacy will fuel the demand in the coming years.

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/immunology-market-100657

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

This release was published on openPR.